Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schall

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
ACS Infectious Diseases|March 13, 2025
Nonstructural Protein 1 of Influenza A (NS1A) Demonstrates Strain-Specific dsRNA Binding CapabilitiesVeronica A Smith, Aubrey R Schall, John W Tomsho
European Journal of Clinical Pharmacology|May 20, 2014
Indirect bioequivalence assessment using network meta-analysesA Ring, T B S Morris, K Hohl, et al.
Clinical Neuropharmacology|January 1, 1994
Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedulesC A Gagiano, G A Hart, W Bodemer, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulationsR Schall, H G Luus, V W Steinijans, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1993
Considerable cost savings through the analysis of pooled plasma samples in bioequivalence studies that fail to show bioequivalenceH K Hundt, R Schall, H G Luus, et al.
Clinical Pharmacokinetics|January 1, 1997
Bioequivalence of controlled-release calcium antagonistsR Schall, F R Müller, F O Müller, et al.
British Journal of Clinical Pharmacology|July 6, 2019
Sample size determination in bioequivalence studies using statistical assuranceA Ring, B Lang, C Kazaroho, et al.
Chronobiology International|June 1, 1993
Theophylline dose-concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal nuelin liquid in healthy volunteersR Schall, M V Middle, F O Müller, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six monthsC A Gagiano, F G Müller, R F de Kock, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1997
[ICPM-independent documentation of new reimbursement forms--method and 1995 results]F X Huber, R Schall, C Fritz-Krieglstein, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
ACS Infectious Diseases|March 13, 2025
Nonstructural Protein 1 of Influenza A (NS1A) Demonstrates Strain-Specific dsRNA Binding CapabilitiesVeronica A Smith, Aubrey R Schall, John W Tomsho
European Journal of Clinical Pharmacology|May 20, 2014
Indirect bioequivalence assessment using network meta-analysesA Ring, T B S Morris, K Hohl, et al.
Clinical Neuropharmacology|January 1, 1994
Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedulesC A Gagiano, G A Hart, W Bodemer, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulationsR Schall, H G Luus, V W Steinijans, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1993
Considerable cost savings through the analysis of pooled plasma samples in bioequivalence studies that fail to show bioequivalenceH K Hundt, R Schall, H G Luus, et al.
Clinical Pharmacokinetics|January 1, 1997
Bioequivalence of controlled-release calcium antagonistsR Schall, F R Müller, F O Müller, et al.
British Journal of Clinical Pharmacology|July 6, 2019
Sample size determination in bioequivalence studies using statistical assuranceA Ring, B Lang, C Kazaroho, et al.
Chronobiology International|June 1, 1993
Theophylline dose-concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal nuelin liquid in healthy volunteersR Schall, M V Middle, F O Müller, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six monthsC A Gagiano, F G Müller, R F de Kock, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1997
[ICPM-independent documentation of new reimbursement forms--method and 1995 results]F X Huber, R Schall, C Fritz-Krieglstein, et al.
Pageof 9